Miazza Jules, Reuthebuch Benedikt, Bruehlmeier Florian, Camponovo Ulisse, Maguire Rory, Koechlin Luca, Vasiloi Ion, Gahl Brigitta, Vöhringer Luise, Reuthebuch Oliver, Eckstein Friedrich, Santer David
Department of Cardiac Surgery, University Hospital of Basel, 4031 Basel, Switzerland.
Medical Faculty, University Basel, 4056 Basel, Switzerland.
Bioengineering (Basel). 2024 Dec 16;11(12):1280. doi: 10.3390/bioengineering11121280.
This study reports of the use of a rigid-plate fixation (RPF) system designed for sternal closure after minimally invasive cardiac surgery (MICS).
This retrospective analysis included all patients undergoing MICS with RPF (Zimmer Biomet, Jacksonville, FL, USA) at our institution. We analyzed in-hospital complications, as well as sternal complications and sternal pain at discharge and at follow-up 7 to 14 months after surgery.
Between June and December 2023, 12 patients underwent RPF during MICS, of which 9 patients were included in the study. The median (IQR) age was 64 years (63 to 71) and two patients (22%) were female. All patients underwent aortic valve replacement, with two patients (22%) undergoing concomitant aortic surgery. RPF was successfully performed in all patients. ICU and in-hospital stay were 1 day (1 to 1) and 9 days (7 to 13), respectively. Patients were first mobilized in the standing position on postoperative day 2 (2 to 2). Four patients (44%) required opiates on the general ward. In-hospital mortality was 0%. At discharge, rates of sternal pain, sternal instability or infection were 0%. After a follow-up time of 343.6 days (217 to 433), median pain intensity using the Visual Analog Scale was 0 (0 to 2). Forty-four percent ( = 4) of patients reported pain at rest. No sternal complications (sternal dehiscence, sternal mal-union, sternal instability, superficial wound infections and deep sternal wound infections) were reported.
In the evolving landscape of cardiac therapies with incentives to reduce surgical burden, RPF showed safety and feasibility. It might become an important tool for sternal closure in minimally invasive cardiac surgery.
本研究报告了一种用于微创心脏手术后胸骨闭合的刚性钢板固定(RPF)系统的应用情况。
这项回顾性分析纳入了在我们机构接受使用RPF(美国佛罗里达州杰克逊维尔的捷迈邦美公司)进行微创心脏手术的所有患者。我们分析了住院期间的并发症,以及出院时和术后7至14个月随访时的胸骨并发症和胸骨疼痛情况。
在2023年6月至12月期间,12例患者在微创心脏手术期间接受了RPF,其中9例患者纳入研究。年龄中位数(四分位间距)为64岁(63至71岁),2例患者(22%)为女性。所有患者均接受了主动脉瓣置换术,2例患者(22%)同时接受了主动脉手术。所有患者均成功进行了RPF。重症监护病房(ICU)和住院时间分别为1天(1至1天)和9天(7至13天)。患者术后第2天(2至2天)首次站立活动。4例患者(44%)在普通病房需要使用阿片类药物。住院死亡率为0%。出院时,胸骨疼痛、胸骨不稳定或感染发生率为0%。随访343.6天(217至433天)后,使用视觉模拟量表的疼痛强度中位数为0(0至2)。44%(n = 4)的患者报告静息时疼痛。未报告胸骨并发症(胸骨裂开、胸骨畸形愈合、胸骨不稳定、浅表伤口感染和深部胸骨伤口感染)。
在旨在减轻手术负担的心脏治疗不断发展的背景下,RPF显示出安全性和可行性。它可能成为微创心脏手术中胸骨闭合的重要工具。